Connect with us

Hi, what are you looking for?

Health

Experts Warn Ozempic-Style Patches May Mislead Weight-Loss Seekers

Recent promotions for weight-loss patches inspired by the drug Ozempic have gained traction online, but experts are urging caution. These patches, often marketed as a painless alternative to injections, promise significant weight loss with minimal evidence to support their claims. Some endorsements circulating on social media, including those from individuals claiming to be medical professionals, have been found to be generated by artificial intelligence.

Understanding the Composition of Ozempic-Style Patches

Also referred to as GLP-1 patches, these products do not contain active pharmaceutical ingredients such as semaglutide—the active component in Ozempic—or similar medications like Mounjaro (tirzepatide). Instead, they typically comprise a blend of herbal extracts, including berberine, green tea (Camellia sinensis), Garcinia cambogia, and bitter orange (Citrus x aurantium L.).

While laboratory studies indicate that some of these ingredients may suppress appetite and aid in glucose regulation, translating those results to real-world weight loss is not straightforward. For instance, research suggests that the consumption of berberine does not lead to substantial weight loss, with one comprehensive review indicating that dosages of up to 3 grams daily only resulted in minor changes in weight and waist circumference.

Further evidence from studies analyzing green tea extract and Garcinia cambogia showed no significant impact on weight loss when dosages were administered over various periods. In fact, a review found that a daily intake of up to 2.4 grams of green tea extract for 13 weeks and over 4 grams of Garcinia cambogia for 17 weeks did not yield weight loss results. Similarly, a daily dose of 54 milligrams of synephrine from bitter orange extract did not lead to any measurable weight loss over eight weeks.

Challenges of Transdermal Delivery

The effectiveness of these patches also raises questions regarding their ability to deliver active ingredients through the skin. The skin’s composition favors the absorption of oily or fat-soluble substances while blocking water-soluble compounds. Since the drug molecules in Ozempic are too large and hydrophilic to be absorbed transdermally, the same may apply to the extracts in the patches. If these extracts are processed in a water-based solution, they are unlikely to penetrate the skin effectively.

Moreover, the amount of herbal extract contained in these patches is minimal. Typically, such patches hold less than 0.1 grams of extract, a far cry from the grams required to produce any noticeable effects as evidenced in clinical studies.

Regulatory Concerns and Safety Issues

In Australia, the Therapeutic Goods Administration (TGA) oversees the regulation of medical products, including herbal supplements. For a herbal product to be sold, it must be registered on the Australian Register of Therapeutic Goods. Currently, there are no Ozempic-style patches on this register, indicating that their quality and safety have not been independently verified.

A study conducted in Australia highlighted risks associated with unregistered herbal products, reporting instances of contamination with undeclared substances, heavy metals, and even prescription drugs such as warfarin. These contaminants pose significant health risks, as they can be absorbed through the skin and enter the bloodstream.

In summary, while the concept of weight-loss patches inspired by Ozempic may appear attractive, their efficacy is unproven, and their safety remains questionable. For those considering weight loss solutions, it is advisable to consult with a healthcare professional who can recommend safe and effective methods tailored to individual health goals.

This article is republished from The Conversation under a Creative Commons license. For further reading, please refer to the original article.

Trending

You May Also Like

Top Stories

UPDATE: NASA is inviting everyone on Earth to send their name to the Moon aboard the Artemis II mission, set to launch no later...

Science

The prophecies of the 16th-century French astrologer Nostradamus continue to captivate audiences as we approach 2026. His cryptic insights, compiled in his 1555 publication...

Top Stories

UPDATE: Authorities have charged 27-year-old Steven Tyler Whitehead with murder following a tragic shooting that critically injured Kimber Mills, a senior cheerleader at Cleveland...

Top Stories

UPDATE: In a stunning turn of events, 18-year-old influencer Piper Rockelle has shattered the previous OnlyFans earnings record set by fellow content creator Sophie...

Top Stories

UPDATE: Pop superstar Ariana Grande is on the road to recovery after testing positive for COVID-19. Her brother, Frankie Grande, shared the encouraging news...

Sports

The UFC event in Abu Dhabi on July 26, 2025, featured a record-breaking performance from Steven Nguyen, who achieved an unprecedented feat by knocking...

Top Stories

URGENT UPDATE: Affordable motorcycle helmets under ₹1000 are now available for safety-conscious riders across India. With road safety becoming a pressing issue, these helmets...

Entertainment

**Kat Izzo Defends Relationship with Dale Moss Amid Controversy** Kat Izzo, a contestant from the reality series *Bachelor in Paradise*, publicly affirmed her relationship...

Entertainment

The upcoming Netflix series, Bon Appétit, Your Majesty, is making headlines due to a significant casting change just ten days before filming commenced. Originally...

Top Stories

UPDATE: Sydney Sweeney’s Baskin-Robbins advertisement is making waves online as backlash intensifies over her recent American Eagle campaign. Just days after critics condemned the...

Top Stories

UPDATE: Chicago Cubs designated hitter Kyle Tucker may have just played his last game for the team as free agency approaches. Following the Cubs’...

Lifestyle

Shares of **Amerant Bancorp** (NYSE:AMTB) received an upgrade from Wall Street Zen on March 10, 2024, transitioning from a hold rating to a buy...

Copyright © All rights reserved. This website provides general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information presented. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult appropriate experts when needed. We are not responsible for any loss or inconvenience resulting from the use of information on this site.